Pangaea Data Helps Clinicians Diagnose More Accurately and Detect Risk Earlier

Pangaea Data

Share on facebook
Share on twitter
Share on linkedin

Pangaea Data uses unsupervised AI algorithms to identify patient cohorts for drug discovery, clinical trials, and real-world evidence (RWE) studies.

The machine learning-based software scans through electronic health records (EHR) and unstructured doctors’ notes to find the right patients based on phenotypes. Better understanding of patient data 50 times faster with 87.5% higher accuracy than text mining and generic Natural Language Processing (NLP).

The startup also develops a library of AI models for different disease areas.